Literature DB >> 36486

Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet.

H Freund, N Yoshimura, J E Fischer.   

Abstract

Therapy of chronic hepatic encephalopathy is often frustrating, limited as it is by the ability to adequately nourish such patients. Protein is needed for repair, but such patients are intolerant of protein. Previous work from this and other laboratories has suggested that the distorted plasma amino acid pattern may be causally related to hepatic encephalopathy. A single, well-studied, long-term patient received therapy with a branched-chain amino-acid-enriched elemental diet that not only enabled adequate nutrition with protein but resulted in improvement in hepatic function as well as reversal of some aspects of hepatic encephalopathy that heretofore have been deemed irreversible. The results confirm that branched-chain-enriched amino acid diets previously successful in the intravenous mode may be successfully used in chronic long-term support of patients with protein intolerance, with improvement in hepatic function secondary to improvement in nutrition.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36486     DOI: 10.1001/jama.242.4.347

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

Review 1.  Parenteral nutrition: current status and concepts.

Authors:  G D Phillips; C L Odgers
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

2.  Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.

Authors:  F Orlandi; U Freddara; M T Candelaresi; A Morettini; G R Corazza; A Di Simone; G Dobrilla; G Cavallini
Journal:  Dig Dis Sci       Date:  1981-06       Impact factor: 3.199

3.  [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].

Authors:  E H Egberts; H Schomerus; W Hamster; P Jürgens
Journal:  Z Ernahrungswiss       Date:  1986-03

4.  Comparison of distal and proximal splenorenal shunts: a randomized prospective trial.

Authors:  J E Fischer; R H Bower; S Atamian; R Welling
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

5.  Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.

Authors:  M Rössle; M Luft; R Herz; B Klein; M Lehmann; W Gerok
Journal:  Klin Wochenschr       Date:  1984-09-17

6.  Changes in pituitary secretion after administration of branched-chain amino acids to patients with hepatic cirrhosis.

Authors:  T Barreca; R Franceschini; V Messina; P Bottaro; E Rolandi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Treatment of liver cirrhosis with branched chain amino acid-supplemented diet.

Authors:  M Okita; A Watanabe; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1981

8.  Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.

Authors:  L S Eriksson; A Persson; J Wahren
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

9.  Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.

Authors:  T Higashi
Journal:  Gastroenterol Jpn       Date:  1982-04

10.  Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients.

Authors:  A McGhee; J M Henderson; W J Millikan; J C Bleier; R Vogel; M Kassouny; D Rudman
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.